Plasma derivatives products
Plasma-derivatives are special medicines requiring high-level technology and knowhow. They are made by separating plasma proteins into components and refining them. Green Cross provides safe plasma-derivatives by applying the most advanced virus inactivation methods, including nano-filtration and solvent detergent.
With the beginning of production in 2019, GCBT will provide plasma-derived products, including intravenous immunoglobulin (IVIG), for the US and Canadian markets. The plant will also produce albumin for the Canadian and Chinese markets.